Internal Medicine, Rheumatology · Rego Park, NY
NPI
1528385739
Since 2010
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
85-49 Eliot Avenue, Suite G
Rego Park, NY, 11374
Phone (718) 424-2663
Groups this clinician bills Medicare through
Medicare paid, 2024
$236K
12,006 services
Medicare patients, 2024
235
Average age 74
Drug cost, 2024
$2.5M
3,031 prescriptions
Company payments, 2025
$1,805
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Shaifali Dugar was code J0897 (injection, denosumab, 1 mg), 2,404 times for 29 patients. In total Shaifali Dugar billed 12,006 services in 36 codes, and Medicare paid $236K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-04-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 2,404 | 29 | $20.69 | $50K |
| 99214 Office E&M - Established | Office | 297 | 143 | $104.69 | $31K |
| 99213 Office E&M - Established | Office | 167 | 118 | $77.57 | $13K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 90 | 15 | $0.72 | $64.96 |
| 96401 Chemotherapy Administration | Office | 82 | 37 | $67.66 | $5,548 |
| 99204 Office E&M - New | Office | 79 | 79 | $144.30 | $11K |
| 73110 X-ray - Upper Extremity | Office | 75 | 39 | $37.51 | $2,813 |
| 73130 X-ray - Upper Extremity | Office | 75 | 39 | $35.34 | $2,650 |
| 36415 Venipuncture Blood Collection | Office | 42 | 37 | $8.65 | $363 |
| 73562 X-ray - Lower Extremity | Office | 28 | 15 | $39.30 | $1,100 |
| 99203 Office E&M - New | Office | 19 | 19 | $103.80 | $1,972 |
| 20610 Joint Injection | Office | 15 | 11 | $57.98 | $870 |
| 99442 Telephone Services | Office | 11 | 11 | $84.61 | $931 |
| 72110 X-ray - Spine and Pelvis | Office | 11 | 11 | $49.81 | $548 |
By year: 2022 $265K for 13,249 services; 2023 $216K for 7,435 services; 2024 $236K for 12,006 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 42 | 37 | $8.65 | $363 |
Medicare prescription drug claims, 2024
In 2024, the drug Shaifali Dugar prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 430 prescriptions and refills. In total Shaifali Dugar wrote 3,031 Medicare prescriptions that cost $2.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 430 | 879 | 148 | $12K |
| Methotrexate Methotrexate Sodium | 387 | 717 | 94 | $12K |
| Prednisone Generic | 327 | 623 | 117 | $2,158 |
| Gabapentin Generic | 224 | 431 | 99 | $2,311 |
| Leflunomide Generic | 206 | 382 | 67 | $16K |
| Folic Acid Generic | 163 | 285 | 44 | $265 |
| Alendronate Sodium Generic | 125 | 247 | 38 | $678 |
| Meloxicam Generic | 123 | 196 | 72 | $386 |
| Diclofenac Sodium Generic | 95 | 118 | 41 | $8,550 |
| Sulfasalazine Generic | 91 | 177 | 27 | $1,792 |
| Humira(Cf) Pen Adalimumab | 85 | 89 | 11 | $591K |
| Prolia Denosumab | 84 | 501 | 54 | $140K |
| Duloxetine Hcl Generic | 75 | 161 | 25 | $1,431 |
| Allopurinol Generic | 72 | 154 | 26 | $510 |
| Enbrel Sureclick Etanercept | 60 | 60 | Under 11 | $421K |
Brand drugs: 517 claims; generic drugs: 2,503 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Shaifali Dugar $1,805 ($1,805 in general payments such as food, travel and fees) from 18 companies. The largest payer was Abbvie Inc. with $352.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 18 | $352 |
| Amgen Inc. AMGN | 14 | $324 |
| Janssen Pharmaceuticals, Inc JNJ | 7 | $162 |
| GlaxoSmithKline, LLC. GSK | 4 | $114 |
| ANI Pharmaceuticals, Inc. ANIP | 5 | $113 |
| Mallinckrodt Hospital Products Inc. | 4 | $112 |
| Lilly USA, LLC LLY | 3 | $86.28 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $81.55 |
| Pfizer Inc. PFE | 3 | $73.53 |
| Janssen Biotech, Inc. JNJ | 4 | $70.6 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.